Effect of isosorbide dinitrate on enzymatically estimated infarction size and on clinical condition of the patients of acute myocardial infarction.
With the aim of reducing myocardial infarction size, isosorbide dinitrate (ISDN) was tried in 27 patients of acute myocardial infarction (AMI). There was 11% reduction of infarction size, in the ISDN treated group, in comparison to that of non treated group, though the result was not statistically significant. But, many of the in-hospital complications were significantly less in the treated group. After a critical analysis of the result it was concluded that a statistically insignificant result, as regard reduction of infarction size in AMI, cannot always exclude the utility of a drug therapy in AMI.
Mukherjee
D
D
N.R.S. Medical College, Calcutta.
Lodh
S K
SK
Sengupta
M
M
Maity
A K
AK
Mondal
A K
AK
Ghose
J C
JC
D003402:Creatine Kinase / Q000032:analysis; D005260:Female; D006801:Humans; D007527:Isoenzymes; D007548:Isosorbide Dinitrate / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000201:enzymology
D007527:Isoenzymes; D003402:Creatine Kinase; D007548:Isosorbide Dinitrate